These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 988059)

  • 1. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
    Fike RM; van Oss CJ
    Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
    Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
    Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 11. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
    Glaves D; Harlos JP; Weiss L
    Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
    Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
    Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
    Zhao BH; Hu JK; Liang JX
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reappraisal of the macrophage electrophoretic mobility (MEM) test for the measurement of lymphokine activity.
    Brown KA; Wolstencroft RA; Booth CG; Dumonde DC
    J Immunol Methods; 1985 Oct; 82(2):189-98. PubMed ID: 3900214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
    Lewkonia RM; Kerr EJ; Irvine WJ
    Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
    Shenton BK; Hughes D; Field EJ
    Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunodiagnosis of malignant tumors. Test of electrophoretic mobility of macrophages].
    Strejcek J; Jíra M; Suhajová E; Písa P; Malbohan I
    Cas Lek Cesk; 1984 Apr; 123(17):511-6. PubMed ID: 6380732
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
    Rawlins GA; Wood JM; Bagshawe KD
    Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Lancet; 1972 Sep; 2(7778):627-9. PubMed ID: 4116778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.